{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"}],"units":"Participants"}],"description":"The changes in the cytokine levels from baseline analyzed by Wilcoxon signed rank test. P values \\< 0.05 were considered statistically significant.","groups":[{"description":"Akt inhibitor MK2206 200 mg orally once a week, repeats every 28 days for up to 12 courses.","id":"OG000","title":"Akt Inhibitor MK2206"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Baseline to up to 30 days post-treatment","title":"Number of Participants With Change in Cytokine Levels With p Values <0.05","type":"SECONDARY","unitOfMeasure":"Participants"}